Manrique MA, Juárez VEI, Chávez GMÁ, Pérez VE, Pérez CT, Álvarez CR, García MAR, Díaz GDC, Bellacetín FÓ, Alejo TO, Santamaría AJR

Language: Spanish
References: 10
Page: 87-92
PDF size: 423.26 Kb.

ABSTRACT

Introduction. The gastric varices presents in 20% of patients with portal hypertension. Sarin’s grading is the most common used. GOV1 is the most frequent (74%). The development of spontaneous portosystemic shunts, between splenic and renal veins (splenorrenal shunt) are frequently, with a rate of 60%. The risk of bleeding has a rate among 25% at 2 years, due to its submucosal localization. The mayor risk of bleeding is for IGV1 y GOV2 (78 y 55% respectively). The first line of treatment for the acute bleeding and secondary profilaxis is the use of adhesive tissue agents. Objective. To describe the prevalence and management of gastric varices in the endoscopic department of Hospital Juarez de México. Material and methods. We included all patients with diagnosis of portal hypertension and chronic liver failure of any etiology in the endoscopic department of Hospital Juarez de Mexico with endoscopic diagnosis of gastric varices from January 2006 to April 2010. All patients underwent to panendoscopy and the variceal obliteration was performed with N – 2 buthyl - cyanoacrylate. Results. We included 257 patients from January 2006 to April 2010, 164 males (63.8%) and 93 females (36.2%), with a ranging age of 48. The gastric varices correspond to 194 with GOV1 (75.4%), 58 GOV 2 (22.5%), 4 IGV1 (1.6%), 1 IGV2 (0.4%). We obliterated 40 gastric varices (16%), with a success rate of 92.5%. Conclusions. The optimal grading transient in an adequate therapeutic decision that impact in a better outcomes in patients with gastric varices.

REFERENCES

1. Muruyama, et al. Current Management of gastric varices. J Nepal Med Assoc 2007; 46(167): 143-50.

2. Sarin SK, Negi S. Management of gastric variceal hemorrhage. Indian J Gastroenterol 2006; 25(1): 25-8.

3. Sarin SK, Iahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, Classification and Natural History of Gastric Varices: A long term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-49.

4. García-Tsao G, Bosch J. Manegement of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 326(9): 823-32.

5. Dib N, et al. Current management of the complications of portal hypertension: variceal bleeding and ascitis. CMAJ 2006: 174(10): 1433-43.

6. Belletrutti, et al. Endoscopic management of gastric varices: Efficacy and outcomes of gluing with N-butyl-2-cyanoacrylate in a North American patient population. Can J Gastroenterol 2008; 22(11): 931-6.

7. Hiroshi Y, Yasuhiro M, Nobuhiko T, Takashi T. New methods for the management of gastric varices, World J Gastroenterol 2006; 12(37): 5926-31.

8. Belletrutti PJ, Romagnuolo J, Hilsden RJ, et al. Endoscopic management of gastric varices: Efficacy and outcomes of gluing with N-butyl-2-cyanoacrylate in a North American patient population. Can J Gastroenterol 2008; 22(11): 931-6.

9. Mumtaz K, Majid S, Hasnain AS, Hameed K, Ahmed A, Hamid S, Jafri W. Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleeding. World J Gastroenterol 2007; 13(8): 1247-51.

10. Katoh, et al. Balloon–occluded retrograde transvenous obliteration for gastric varices: The relationship between the clinical outcome and gastrorenal shunt occlusion. BMC Medical Imaging 2010; 10: 2.